<DOC>
	<DOCNO>NCT00518245</DOCNO>
	<brief_summary>The purpose study determine whether enoxaparin ( anticoagulant ) effective treatment patient present emergency room chest pain electrocardiogram bloodwork evidence heart attack , high risk clinical feature</brief_summary>
	<brief_title>Ischemia Driven Enoxaparin Therapy ACS Presenting Low Risk ( IDEAL )</brief_title>
	<detailed_description>Patients chest pain abnormal electrocardiogram bloodwork ( biomarker ) indicative heart attack benefit anticoagulant therapy enoxaparin . However , even patient without abnormality electrocardiogram bloodwork increase risk heart attack death , certain clinical risk factor . It currently know whether enoxaparin also beneficial patient . Comparison : enoxaparin addition optimal standard care discretion treat physician , versus optimal standard care without enoxaparin</detailed_description>
	<mesh_term>Angina , Unstable</mesh_term>
	<criteria>Male female ( negative pregnancy test require female childbearing potential ) â‰¥ 18 year age capable signing informed consent ; Typical chest discomfort rest ; last least 5 minute prior 24 hour highly suggestive myocardial ischemia explain trauma obvious abnormality chest xray ; Two highrisk clinical feature . Clear indication low molecular weight unfractionated heparin ; Pregnancy ; Increased bleeding risk ; Impaired hemostasis ; Angina secondary cause ; Inability commence ST segment monitoring within 4 hour study drug initiation ; Uninterpretable ST segment base upon baseline 12lead ECG ; Any contraindication treatment LMWH ( unfractionated heparin ) , include heparin induce thrombocytopenia , know allergy heparin , low molecular weight heparin , pork pork product ; Renal insufficiency renal dialysis ; A prosthetic heart valve ; Any clinically relevant serious disease ; Current evidence inebriation alcohol intoxication result drug abuse ; Treatment investigational agent device within previous 30 day , plan use investigational drug device , previously enrol trial ; Inability comply protocol ; Inability understand nature , scope , possible consequence study otherwise unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>unstable angina</keyword>
	<keyword>drug therapy</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>hemorrhage</keyword>
</DOC>